Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Zika clinical updates: implications for pediatrics

Adachi, Kristina; Nielsen-Saines, Karin

doi: 10.1097/MOP.0000000000000582
INFECTIOUS DISEASES AND IMMUNIZATION: Edited by Yvonne J. Bryson

Purpose of review Zika virus (ZIKV), a mosquito-borne flavivirus, has gained recognition over the past few years as an important new cause of congenital infection. As a result, it is critical that pediatricians understand its epidemiology, clinical presentation, clinical sequelae, and management.

Recent findings The recent ZIKV epidemiology, clinical presentation of acute infection in children and complications, perinatal infection, and congenital infection will be summarized in this ZIKV review. This will be followed by a brief summary on ZIKV diagnosis, management, treatment, and prevention.

Summary The field of clinical research in ZIKV has rapidly evolved over recent months. It is critical that pediatricians continue to stay up-to-date with the continuously evolving understanding of the clinical aspects of ZIKV to ensure optimal identification and management of affected infants and children. Given the recent changes in Centers for Disease Control and Prevention guidelines to limit screening of asymptomatic pregnant women in the United States with possible ZIKV exposure, comprehensive ZIKV clinical knowledge becomes even more crucial.

Department of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA

Correspondence to Kristina Adachi, MD, Department of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, MDCC 22-442, Los Angeles, CA 90095-1752, USA. Tel: +1 310 825 5235; fax: +1 310 206 4764; e-mail: kadachi@mednet.ucla.edu

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.